Brief Profile

Data platform availability banner - brief profile

Please be aware that the REACH registration parts of this Brief Profile are no longer maintained; they remain frozen as of 19th May 2023. All other data parts (substance identity, C&L, key regulatory lists etc. are up to date).

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

No image available
EC / List no.:
272-883-2
CAS no.:
68919-10-8
Index number:
649-106-00-4
Molecular formula:
SMILES:
InChI:
Type of substance:
UVCB
Origin:
Petroleum product
Registered compositions:
4
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
EINECS (European INventory of Existing Commercial chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (ATP01corr) approved by the European Union, this substance may cause genetic defects, may cause cancer and is an extremely flammable gas.

Breakdown of all 0 C&L notifications submitted to ECHA

Muta. 1B H340 Harmonised Classification
Carc. 1A H350 Harmonised Classification
Flam. Gas 1 H220 Harmonised Classification
Press. Gas Harmonised Classification
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

  • C
Officially recognised in the EU as Carcinogenic (Harmonised C&L).
  • M
Officially recognised in the EU as Mutagenic (Harmonised C&L).

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 1 active registrations under REACH, 1 Joint Submission(s) and 0 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Registration dossiers submitted to ECHA for this substance have been evaluated under REACH.
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Industrial accident prevention and reporting requirements have been established for this substance.
Notified C&L:

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, at ≥ 1 to < 10 tonnes per annum.

This substance is used by consumers, by professional workers (widespread uses), in formulation or re-packing, at industrial sites and in manufacturing.

This substance is used in the following products: fuels, air care products and coating products.

Other release to the environment of this substance is likely to occur from: indoor use as processing aid, outdoor use as processing aid, indoor use in close systems with minimal release (e.g. cooling liquids in refrigerators, oil-based electric heaters) and outdoor use in close systems with minimal release (e.g. hydraulic liquids in automotive suspension, lubricants in motor oil and break fluids).

ECHA has no public registered data on the use of this substance in activities or processes at the workplace.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

ECHA has no public registered data indicating whether or into which articles the substance might have been processed.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the types of manufacture using this substance.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed processes with no likelihood of exposure and closed, continuous processes with occasional controlled exposure.

Other release to the environment of this substance is likely to occur from: indoor use in close systems with minimal release (e.g. cooling liquids in refrigerators, oil-based electric heaters), outdoor use in close systems with minimal release (e.g. hydraulic liquids in automotive suspension, lubricants in motor oil and break fluids), indoor use as processing aid and outdoor use as processing aid.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

This substance is used in the following activities or processes at workplace: closed, continuous processes with occasional controlled exposure, transfer of chemicals, transfer of substance into small containers, closed processes with no likelihood of exposure, closed batch processing in synthesis or formulation, batch processing in synthesis or formulation with opportunity for exposure, mixing in open batch processes and laboratory work.

Release to the environment of this substance can occur from industrial use: formulation of mixtures.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

This substance is used for the manufacture of: chemicals.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed, continuous processes with occasional controlled exposure, closed processes with no likelihood of exposure, closed batch processing in synthesis or formulation and batch processing in synthesis or formulation with opportunity for exposure.

Release to the environment of this substance can occur from industrial use: in processing aids at industrial sites, as an intermediate step in further manufacturing of another substance (use of intermediates) and of substances in closed systems with minimal release.

This substance is used in the following activities or processes at workplace: transfer of chemicals, closed, continuous processes with occasional controlled exposure, closed processes with no likelihood of exposure, closed batch processing in synthesis or formulation, batch processing in synthesis or formulation with opportunity for exposure, transfer of substance into small containers and laboratory work.

Release to the environment of this substance can occur from industrial use: manufacturing of the substance.

Precautions for using this substance have been recommended by its registrants under REACH, as follows:

Prevention statements

When handling this substance: obtain special instructions before use; keep away from heat, sparks, open flames and/or hot surfaces – No smoking; wash parts of the body (as specified by manufacturer/supplier)in contact with substance thoroughly after handling; avoid release to the environment; do not handle until all safety precautions have been read and understood; do not breathe the dust, fume, gas, mist, vapours or spray; avoid breathing the dust, fume, gas, mist, vapours or spray; do not eat, drink or smoke when using this product; use only outdoors or in a well-ventilated area; wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier.

Response statements

In case of incident: In case of leaking gas fire do not extinguish unless leak can be stopped safely. In case of leakage eliminate all ignition sources. If swallowed: immediately call a poison center or doctor/physician. Call a poison center or doctor/physician if you feel unwell. Get medical advice/attention if you feel unwell. Do not induce vomiting. If inhaled: remove victim to fresh air and keep at rest in a position comfortable for breathing. If exposed or concerned: get medical advice/attention. Collect spillage.

Storage statements

Store this substance locked up; in a well-ventilated place and keeping container tightly closed; protected from sunlight.

Disposal statements

The substance must be disposed in accordance with local/regional/national/international regulation.

Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • ConocoPhillips Skandinavia AS, Ekofiskvegen 35 4056 Tananger Norway

Substance names and other identifiers

[A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Other
Gases (petroleum), straight-run stabiliser off
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Cosmetic Products Regulation, Annex II - Prohibited Substances
Gases (petroleum), straight-run stabilizer off
EC Inventory, Other
Gases (petroleum), straight-run stabilizer off Petroleum gas [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
C&L Inventory
Gases (petroleum), straight-run stabilizer off
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
REACH pre-registration, Other
Gases (petroleum), straight-run stabilizer off; Petroleum gas [ complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances
Gases (petroleum), straight-run stabilizer off; Petroleum gas [A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.]
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
FCM Active and Intelligent Materials - CMRs not allowed for use, Aerosols Directive - Flammable Contents - Labelling Requirements, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, Protection of Pregnant and Breastfeeding Workers Directive, Annex I+II, Pressure Equipment Directive - Group 1 Fluids Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties, Carc and Muta Directive, Annex I - Substances, Mixtures & Processes, Physical, Biological and Chemical Agents & Processes and Work
Gases, petroleum, straight-run stabilizer off
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Other
Petroleum gas
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Other
Straight run stabilizer off-gas
A complex combination of hydrocarbons obtained from the fractionation of the liquid from the first tower used in the distillation of crude oil. It consists of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C1 through C4.
Other
(Keerulise koostisega süsivesinike segu, mis saadakse toorõli destillatsiooni esimesest kolonnist saadava vedeliku fraktsioonimisel. Koosneb küllastunud alifaatsetest süsivesinikest süsiniku aatomite arvuga valdavalt vahemikus C1 kuni C4.) (et)
Other
[Kompleks blanding av hydrokarboner dannet ved fraksjonering av væsken fra det første tårnet brukt ved destillasjon av råolje. Består av mettede, alifatiske hydrokarboner, hovedsakelig C1 til C4.] (no)
Other
[Kompleksna kombinacija ogljikovodikov dobljena s frakcioniranjem tekočine iz prve kolone za destilacijo surovega olja. Sestoji iz nasičenih alifatskih ogljikovodikov s številom ogljikovih atomov pretežno v območju med C1 in C4.] (sl)
Other
[komplexe Kombination von Kohlenwasserstoffen, erhalten durch Fraktionierung der Flüssigkeit aus der ersten Kolonne bei der Destillation von Rohöl; besteht aus gesättigten aliphatischen Kohlenwasserstoffen mit Kohlenstoffzahlen vorwiegend im Bereich von C1 bis C4] (de)
Other
[Komplexná zmes uhľovodíkov získavaná frakcionovaním kvapaliny z prvej veže (preflešovej alebo atmosférickej kolóny), používanej pri destilácii ropy. Pozostáva z nasýtených alifatických uhľovodíkov s počtom atómov uhlíka prevažne v rozmedzí od C1 do C4.] (sk)
Other
[O combinaţie complexă de hidrocarburi obţinută prin fracţionarea lichidului rezultat în primul turn în procesul de distilare a uleiului brut. Constă în hidrocarburi alifatice saturate al căror număr de atomi de carbon variază între C1 şi C4.] (ro)
Other
[Ogļūdeņražu savienojumu komplekss, ko iegūst, pakļaujot frakcionēšanai šķidro produktu no jēlnaftas destilācijas pirmās kolonnas. Satur piesātinātos alifātiskos ogļūdeņražus, pārsvarā ar oglekļa atomu skaitu no C1 līdz C4.] (lv)
Other
[Složeni sastav ugljikovodika dobivenih frakcionacijom tekućine iz prve kolone upotrebljene u destilaciji sirove nafte. Sastoji se od zasićenih alifatskih ugljikovodika koji imaju broj ugljikovih atoma pretežito u području C1 do C4.] (hr)
Other
[Složitá směs uhlovodíků získaná z frakční destilace kapaliny z první věže při destilaci ropy. Je složena z nasycených alifatických uhlovodíků s počtem uhlíkových atomů převážně v rozmezí C1 až C4.] (cs)
Other
[Sudėtinis angliavandenilių mišinys, gaunamas frakcionuojant skystį iš pirmosios kolonos, naudojamos žaliai naftai distiliuoti. Jį sudaro sotieji alifatiniai angliavandeniliai, turintys anglies atomų skaičių daugiausia nuo C1 iki C4.] (lt)
Other
[Szénhidrogének komplex elegye, melyet a nyersolaj desztillációjánál használt első toronyból nyert folyadék frakcionálásával állítanak elő. Telített alifás szénhidrogénekből áll, melyek szénatomszáma főleg a C1-C4 tartományban van.] (hu)
Other
[Złożona mieszanina węglowodorów otrzymana przez frakcjonowanie roztworu na pierwszej kolumnie stosowanej do destylacji surowego oleju. Składa się z nasyconych węglowodorów alifatycznych o liczbie atomów węgla zasadniczo w zakresie C1 do C4.] (pl)
Other
[Πολύπλοκος συνδυασμός υδρογονανθράκων που λαμβάνεται από την κλασμάτωση του υγρού από την πρώτη στήλη που χρησιμοποιείται στην απόσταξη αργού πετρλαίου. Συνίσταται από κορεσμένους αλειφατικούς υδρογονάνθρακες με αριθμό ατόμων άνθρακα κυρίως μεταξύ C1 και C4.] (el)
Other
[Комплексна комбинация от въглеводороди, получена при фракциониране на течността от първата ректификационна колона, използвана за дестилация на суров нефт. Състои се от наситени алифатни въглеводороди с брой на въглеродните атоми преобладаващо в интервала от С1 до С4 включително.] (bg)
Other
combinación compleja de hidrocarburos obtenida del fraccionamiento del líquido de la primera torre utilizada en la destilación del petróleo crudo; compuesta de hidrocarburos alifáticos saturados con un número de carbonos en su mayor parte dentro del intervalo de C1 a C4 (es)
Other
Combinaison complexe d'hydrocarbures obtenue par fractionnement du liquide issu de la première tour utilisée dans la distillation du pétrole brut. Se compose d'hydrocarbures aliphatiques saturés dont le nombre de carbones se situe principalement dans la gamme C1-C4. (fr)
Other
Combinazione complessa di idrocarburi ottenuta dal frazionamento del liquido proveniente dalla prima torre usata nella distillazione del grezzo. È costituita da idrocarburi alifatici saturi con numero di atomi di carbonio prevalentemente nell'intervallo C1-C4. (it)
Other
Combinação complexa de hidrocarbonetos obtida por fraccionamento do líquido da primeira coluna utilizada na destilação do petróleo bruto. É constituída por hidrocarbonetos alifáticos saturados com número de átomos de carbono predominantemente na gama C1 a C4. (pt)
Other
Dujos (nafta), tiesioginio distiliavimo stabilizavimo įrenginys (lt)
Other
Een complexe verzameling koolwaterstoffen die wordt verkregen uit de fractionering van de vloeistof uit de eerste destillatietoren die wordt gebruikt bij de destillatie van ruwe olie. Bestaat uit verzadigde alifatische koolwaterstoffen, overwegend C1 tot en met C4. (nl)
Other
En sammensat blanding af carbonhydrider opnået ved fraktioneringen af væsken fra det første tårn brugt ved destillationen af råolie. Den består af mættede aliphatiske carbonhydrider, overvejende C1 til og med C4. (da)
Other
Gaasid (nafta), otsedestillatsiooni produktide stabiliseerimisseadme heitgaas (et)
Other
gas (petrolio), dallo stabilizzatore di prima distillazione (it)
Other
gas di petrolio (it)
Other
Gase (Erdöl), Abgase von Straight-run-Benzin, Stabilisationskolonne (de)
Other
Gase aus der Erdölverarbeitung (de)
Other
Gaser (petroleum), straight-run stabilisatoravgaser (sv)
Other
Gases (petróleo), de estabilizador de destilação directa (pt)
Other
gases (petróleo), del estabilizador de fracciones de primera destilación (es)
Other
gases de petróleo (es)
Other
Gassen (aardolie), directe fractionering, stabilisatoruitstoot (nl)
Other
gasser (petroleum), direktedestillert (straight-run) stabilisatoravgasser (no)
Other
gasser (råolie), straight-run stabilizeraftræks- (da)
Other
gaz de pétrole (fr)
Other
Gaz petrolier (mt)
Other
Gaz petrolier (ro)
Other
Gaz résiduels (pétrole), stabilisation des coupes de distillation directe;gaz de pétrole;[combinaison complexe d'hydrocarbures obtenue par fractionnement du liquide issu de la première tour utilisée dans la distillation du pétrole brut. Se compose d'hydrocarbures aliphatiques saturés comportant majoritairement entre 1 et 4 atomes de carbone (C1-C4).] (fr)
Other
Gaz z ropy naftowej (pl)
Other
Gaze reziduale (petrol), stabilizarea fracţiilor de distilare directă (mt)
Other
Gaze reziduale (petrol), stabilizarea fracţiilor de distilare directă (ro)
Other
Gazy po stabilizacji surowej benzyny (ropa naftowa) (pl)
Other
Gás de petróleo (pt)
Other
Gázok (nyersolaj), közvetlen stabilizáló távozó terméke (hu)
Other
Gāzes (nafta), tiešās destilācijas stabilizators (lv)
Other
Kaasut (maaöljy), suoratislausstabilointiyksikön poisto (fi)
Other
Komplex blandning av kolväten från fraktionering av vätskan från det första tornet vid destillation av råolja. Består av mättade alifatiska kolväten, främst C1 till C4. (sv)
Other
Kulbrintegasser (da)
Other
Kőolaj gáz (hu)
Other
Maaöljykaasu (fi)
Other
Monimutkainen seos hiilivetyjä, saatu jakotislaamalla nestettä ensimmäisestä tornista, jota käytetään raakaöljyn tislaukseen. Koostuu tyydyttyneistä alifaattisista hiilivedyistä, joiden hiililuvut ovat pääasiassa välillä C1:stä C4:een. (fi)
Other
Naftagaas (et)
Other
Naftas gāze (lv)
Other
Naftni plin (hr)
Other
Naftos dujos (lt)
Other
O combinaţie complexă de hidrocarburi obţinută prin fracţionarea lichidului rezultat în primul turn în procesul de distilare a uleiului brut. Constă în hidrocarburi alifatice saturate al căror număr de atomi de carbon variază între C1 şi C4. (mt)
Other
Petroleumgas (nl)
Other
Petroleumgas (sv)
Other
petroleumsgass (no)
Other
plin iz predelave zemeljskega olja (sl)
Other
plini (zemeljsko olje), iz stabilizatorjev direktne destilacije (sl)
Other
Plinovi (nafta), iz primarnog stabilizatora (hr)
Other
plyn zo spracovania ropy (sk)
Other
Plyny (ropné), primární výstup stabilizační kolony (cs)
Other
plyny (ropné), zo stabilizácie primárneho ťažkého benzínu (sk)
Other
Ropný plyn (cs)
Other
Ααέρια (πετρελαίου), εξόδου σταθεροποιητή προϊόντων απευθείας απόσταξης (el)
Other
Πετρελαϊκό αέριο (el)
Other
Газове (нефт), на изход от прякодестилатния стабилизатор (bg)
Other
Нефтен газ (bg)
Other
Gases (petroleum), straight-run stabilizer off
Other
Gases (petroleum), straight-run stabilizer off
Registration dossier
Gases (petroleum), straight-run stabilizer off
Registration dossier
649-106-00-4
Index number
C&L Inventory, Other
68919-10-8
CAS number
EC Inventory, C&L Inventory, Registration dossier, REACH pre-registration, Other, FCM Active and Intelligent Materials - CMRs not allowed for use, Aerosols Directive - Flammable Contents - Labelling Requirements, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, Cosmetic Products Regulation, Annex II - Prohibited Substances, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Regulation - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, Medical Devices Regulation - Hazardous Substances, Protection of Pregnant and Breastfeeding Workers Directive, Annex I+II, Pressure Equipment Directive - Group 1 Fluids Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties, Carc and Muta Directive, Annex I - Substances, Mixtures & Processes, Physical, Biological and Chemical Agents & Processes and Work

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 19 studies submitted
  • 8 studies processed
C Physical state at 20°C and 1013 hPa
Gaseous (100%) [8]
C Form
Liquified gas (100%) [7]
C Odour
Other (67%), Odourless (17%), Slight (17%) [6]
C Substance type
Petroleum product (100%) [6]

Type of Study provided
Studies with data
Key study 8
Supporting study 11
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Physical state at 20°C and 1013 hPa
Gaseous (50%), Liquid (50%)
Form
Gas under pressure: liquefied gas (100%)
Colour
colourless (100%)

Melting/freezing point

Study results
  • 14 studies submitted
  • 11 studies processed
R Melting / freezing point
-187.6 - -105.52 °C @ 101.3 kPa [11]

Type of Study provided
Studies with data
Key study 11
Supporting study 3
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Melting / freezing point at 101 325 Pa
-153.5 - 5.49 °C

Boiling point

Study results
  • 14 studies submitted
  • 10 studies processed
R Boiling point
-161.48 - 3.71 °C @ 101.3 - 101.325 kPa [10]

Type of Study provided
Studies with data
Key study 10
Supporting study 4
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Boiling point at 101 325 Pa
-29.6 - 80.09 °C

Density

Study results
  • 17 studies submitted
  • 11 studies processed
R Density
0.001 - 0.589 g/cm³ @ -162 - 25 °C [6]
R Relative density
0.56 - 0.98 @ 20 - 25 °C [6]

Type of Study provided
Studies with data
Key study 11
Supporting study 5
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Relative density at 20°C
0.598 - 0.876

Vapour pressure

Study results
  • 11 studies submitted
  • 10 studies processed
R Vapour pressure
100 - 50 400 000 000 000 000 kPa @ -161.7 - 26.85 °C [31]

Type of Study provided
Studies with data
Key study 10
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Vapour pressure
99.5 - 8 720 hPa @ 20 - 22 °C

Partition coefficient

Study results
  • 13 studies submitted
  • 13 studies processed
R Log Pow
1.09 - 3.39 @ 20 °C and pH 7 [13]

Type of Study provided
Studies with data
Key study 12 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Log Kow (Log Pow)
2.13 - 2.17 @ 20 °C

Water solubility

Study results
  • 23 studies submitted
  • 6 studies processed
R Water solubility (mass/vol.)
131 - 735 mg/L @ 20 - 25 °C and pH 7 [6]

Type of Study provided
Studies with data
Key study 11
Supporting study 12
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 2 summaries submitted
  • 2 summaries processed
Water solubility
186.5 - 1 880 mg/L @ 23.5 - 25 °C

Solubility in organic solvents / fat solubility

Study results
  • 5 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study 3
Weight of evidence
Other 2
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Surface tension

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Flash point

Study results
  • 4 studies submitted
  • 3 studies processed
R Flash point
-104 - -60 °C @ 101.3 kPa [3]

Type of Study provided
Studies with data
Key study 3
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Flash point at 101 325 Pa
-84 °C

Auto flammability

Study results
  • 15 studies submitted
  • 12 studies processed
R Autoflammability / self-ignition
287 - 537 °C @ 99.8 - 102.1 kPa [12]

Type of Study provided
Studies with data
Key study 12
Supporting study 2
Weight of evidence
Other 1
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Autoflammability / self-ignition at 101 325 Pa
426 °C

Flammability

Study results
  • 15 studies submitted
  • 9 studies processed
C Interpretation of results
Extremely flammable (100%) [9]

Type of Study provided
Studies with data
Key study 11
Supporting study 3
Weight of evidence
Other 1
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Flammability
Extremely flammable (100%)

Explosiveness

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidising

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Viscosity

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Study results
  • 8 studies submitted
  • 8 studies processed
R Dissipation half life (DT50)
5.76 - 45 768 h [8]

Type of Study provided
Studies with data
Key study 3 5
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Half life in air
12.5 days

Hydrolysis

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 22 studies submitted
  • 2 studies processed
C Interpretation of results
Readily biodegradable (100%) [2]

Type of Study provided
Studies with data
Key study 2
Supporting study 2
Weight of evidence 3 15
Other
Data waiving
no waivers
C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Biodegradation in water
Readily biodegradable (100%)

Biodegradation in water & sediment - simulation tests

Study results
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Biodegradation in soil

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Bioaccumulation: aquatic / sediment

Study results
  • 15 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 15
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Study results
  • 16 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study 1
Weight of evidence 15
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

R Summaries
  • 2 summaries submitted
  • 2 summaries processed

The Predicted No-Effect Concentration (PNEC) value is the concentration of a substance below which adverse effects in the environment are not expected to occur. Please note that when more than one summary is provided, PNEC values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Hazard for Aquatic Organisms
Freshwater 80 µg/L (1)
Intermittent releases (freshwater) 53 µg/L (1)
Marine water 8 µg/L (1)
Intermittent releases (marine water) 5.3 µg/L (1)
Sewage treatment plant (STP) 39 mg/L (1)
Sediment (freshwater) 1.36 mg/kg sediment dw (1)
Sediment (marine water) 136 µg/kg sediment dw (1)
Hazard for Air
Air Hazard related to composition of atmosphere identified (2)
Hazard for Terrestrial Organism
Soil 225 µg/kg soil dw (1)
Hazard for Predators
Secondary poisoning No potential for bioaccumulation (2)

Short–term toxicity to fish

Study results
  • 15 studies submitted
  • 15 studies processed
P/RResults
LC50 (4 days) 5.3 - 627.644 mg/L [15]

Type of Study provided
Studies with data
Key study 1 14
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to fish

Study results
  • 15 studies submitted
  • 1 study processed
P/RResults
NOEC (32 days) 800 µg/L [2]
LOEC (32 days) 1.6 mg/L [2]

Type of Study provided
Studies with data
Key study 1 14
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Short–term toxicity to aquatic invertebrates

Study results
  • 15 studies submitted
  • 15 studies processed
P/RResults
EC50 (48 h) 10 mg/L [1]
EC50 (24 h) 10 mg/L [1]
LC50 (48 h) 6.971 - 307.472 mg/L [14]

Type of Study provided
Studies with data
Key study 1 14
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to aquatic invertebrates

Study results
  • 15 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1 14
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Toxicity to aquatic algae and cyanobacteria

Study results
  • 15 studies submitted
  • 15 studies processed
P/RResults
EC50 (4 days) 7.039 - 124.406 mg/L [14]
EC50 (72 h) 32 - 100 mg/L [2]
EC10 (72 h) 10 - 34 mg/L [2]

Type of Study provided
Studies with data
Key study 1 14
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Sediment toxicity

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial arthropods

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to terrestrial plants

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 2
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to soil microorganisms

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to birds

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No data available

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed

The derived no- or minimum effect level (DN(M)EL) is the level of exposure above which a human should not be exposed to a substance. Please note that when more than one summary is provided, DN(M)EL values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.

Data for WORKERS
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DMEL) 2.21 mg/m³ carcinogenicity
Acute /short term: High hazard (no threshold derived)
Local Effects
Long-term: No hazard identified
Acute /short term: No hazard identified
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: High hazard (no threshold derived)
Acute /short term: High hazard (no threshold derived)
Local Effects
Long-term: Low hazard (no threshold derived)
Acute /short term: Low hazard (no threshold derived)
EYE Exposure
Low hazard (no threshold derived)
Data for the GENERAL POPULATION
INHALATION Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DNEL) 140 µg/m³ repeated dose toxicity
Acute /short term: Hazard unknown (no further information necessary as no exposure expected)
Local Effects
Long-term: Hazard unknown (no further information necessary as no exposure expected)
Acute /short term: Hazard unknown (no further information necessary as no exposure expected)
DERMAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: Hazard unknown (no further information necessary as no exposure expected)
Acute /short term: Hazard unknown (no further information necessary as no exposure expected)
Local Effects
Long-term: Hazard unknown (no further information necessary as no exposure expected)
Acute /short term: Hazard unknown (no further information necessary as no exposure expected)
ORAL Exposure Threshold Most sensitive study
Systemic Effects
Long-term: (DMEL) 464 ng/kg bw/day carcinogenicity
Acute /short term: Hazard unknown (no further information necessary as no exposure expected)
EYE Exposure
Hazard unknown (no further information necessary as no exposure expected)

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 14 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study 8
Supporting study 6
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal absorption
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Bioaccumulation potential:
Low bioaccumulation potential
Absorption values
Oral: 100 %
Dermal: 0.1 %
Inhalation: 100 %

Acute toxicity

Study results
oral
  • 3 studies submitted
  • 1 study processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
M/CInterpretations of results
Not classified [1]

Type of Study provided
oral
Studies with data
Key study 1
Supporting study 1
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
inhalation
  • 21 studies submitted
  • 7 studies processed
P/RResults
LC50 (4 h) 43.767 - 65.4 mg/L air (rat) [2]
LC50 (4 h) 13 700 - 57 000 ppm (rat) [2]
LC50 (15 min) 1 442.738 - 1 443 mg/L air (rat) [2]
LC50 (15 min) 800 000 ppm (rat) [1]
LC50 (2 h) 1 237 mg/L air (mouse) [1]
M/CInterpretations of results
Not classified [7]

inhalation
Studies with data
Key study 7
Supporting study 7
Weight of evidence 4
Other 3
Data waiving
no waivers
dermal
  • 2 studies submitted
  • 1 study processed
M/CInterpretations of results
Not classified [1]

dermal
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oral route:
No adverse effect observed LD50 2 000 mg/kg bw
Inhalation route:
No adverse effect observed LC50 22.948 mg/L air
Dermal route:
No adverse effect observed LD50 8 260 mg/kg bw

Irritation / corrosion

Study results
Study data: skin
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 2
Supporting study 1
Weight of evidence
Other 1
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Study data: eye
  • 4 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study 2
Supporting study
Weight of evidence
Other 1
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Skin
Adverse effect observed (irritating)
Eye
Adverse effect observed (irritating)
Respiratory
No study available

Sensitisation

Study results
Study data: skin
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Study data: respiratory
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified
Exposure cons.
Other 1
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Skin sensitisation
No adverse effect observed (not sensitising)
Respiratory sensitisation
No study available

Repeated dose toxicity

Study results
Study data: oral
  • 2 studies submitted
  • 2 studies processed
P/RResults
NOAEL (rat): 100 - 148.6 mg/kg bw/day [2]
LOAEL (rat): 25 - 200 mg/kg bw/day [2]

Type of Study provided
Study data: oral
Studies with data
Key study 2
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: inhalation
  • 30 studies submitted
  • 18 studies processed
P/RResults
NOAEC (rat): 96 - 21 394 mg/m³ air [5]
NOAEC (rat): 30 - 16 000 ppm [9]
NOAEC (mouse): 32 - 96 mg/m³ air [2]
NOAEC (mouse): 10 - 10 000 ppm [4]
NOAEC (other:): 0.59 ppm [1]

Study data: inhalation
Studies with data
Key study 24
Supporting study 6
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oral route - systemic effects:
Adverse effect observed LOAEL 25 mg/kg bw/day (chronic, rat)
Inhalation route - systemic effects:
No adverse effect observed NOAEC 7 214 mg/m³ (chronic, rat)
Inhalation route - local effects:
Adverse effect observed LOAEC 8 600 mg/m³ (chronic, rat)

Genetic toxicity

Study results
Study data: in vitro
  • 30 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study 29
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
Study data: in vivo
  • 18 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study 15
Supporting study 3
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Toxicity - InVitro
No adverse effect observed (negative)
Toxicity - InVivo
Adverse effect observed (positive)

Carcinogenicity

Study results
  • 22 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 11
Supporting study 11
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 2 summaries processed
Oral route:
Adverse effect observed LOAEL 25 mg/kg bw/day (chronic, mouse)
Inhalation route:
No adverse effect observed NOAEC 3 445 mg/m³ (chronic, rat)

Toxicity to reproduction

Study results
Study data: reproduction
  • 16 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: reproduction
Studies with data
Key study 11
Supporting study 2
Weight of evidence 2
Other 1
Data waiving
no waivers
Study data: developmental
  • 18 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: developmental
Studies with data
Key study 17
Supporting study
Weight of evidence
Other 1
Data waiving
no waivers
Study data: other studies
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: other studies
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 2 summaries submitted
  • 1 summary processed
Effect on fertility
Inhalation route:
Adverse effect observed NOAEC 5 700 mg/m³ (subchronic, rat)
Effect on developmental toxicity
Inhalation route:
No adverse effect observed NOAEC 5 737 mg/m³ (subchronic, rat)

Neurotoxicity

Study results
  • 5 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 5
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Inhalation route:
No adverse effect observed NOAEC 10 257 mg/m³ (subchronic, rat)

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study 1
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 0 summaries submitted
  • 0 summaries processed

No summary exists for this scientific endpoint